Login to Your Account



Washington Roundup

CBO: Key to Innovation is Making it a National Priority

By Mari Serebrov
Washington Editor

Wednesday, April 24, 2013
To spur innovation in biopharma and other industries, Congress must make it a national priority, according to the Congressional Budget Office (CBO). In a review of the nation's commitment to innovation over the past three decades, CBO Director Douglas Elmendorf noted the decrease in federal spending on R&D, relative to GDP, and the decline of innovation as a priority in regulatory policy.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription